📊 Q3 Earnings are here! Plan ahead with key data on upcoming stock reports - all in 1 placeSee list

CVS Health Stock Pops Before Q4 Earnings: What To Expect

Published 02/19/2019, 05:46 AM
Updated 07/09/2023, 06:31 AM
AMZN
-
WMT
-
AET
-
CVS
-
WBA
-
US90274J5618=UBSS
-

CVS Health (NYSE:CVS) shares jumped 0.50% during regular trading hours Tuesday in continuation of a strong month for the pharmacy firm. So, let’s see what to expect from CVS’ fourth-quarter financial results that are due out before the opening bell Wednesday.

Overview

CVS completed its nearly $70 billion acquisition of Aetna (NYSE:AET) in November 2018. The new firm could end up playing a bigger role in a health care environment that seems likely to feature more virtual medical checkups and hyper-localized care. CVS’ purchase also helps expand its reach as Amazon (NASDAQ:AMZN) and others venture into the pharmaceutical business.

Any post-earnings momentum from CVS will come as welcome news to investors because we can see that the stock has dramatically underperformed the market over the last three years. CVS stock has also lagged Walgreens Boots Alliance (NASDAQ:WBA) but topped Rite Aid (NYSE:RAD) .

Outlook

Our current Zacks Consensus Estimate calls for CVS’ Q4 revenues to reach $53.71 billion. This would represent an 11% jump from the prior-year quarter and easily beat Q3’s 2.4% top-line expansion and Q4 2017’s 5.3% growth. Meanwhile, CVS’ same-store retail sales are projected to jump 4.69% and pharmacy comps are expected to pop 6.41%, based on our NFM estimates. Investors should note that both of these would mark a downturn from the third quarter.

Moving on, CVS is projected to see its adjusted quarterly earnings pop 7.81% to hit $2.07 per share. This would also mark a downturn from Q3’s 15.3% bottom-line expansion. Plus, CVS has seen its earnings estimate revision picture turn negative over the last 60 days for Q4 and coming periods.

CVS is scheduled to release its Q4 2018 financial results before the market opens on Wednesday. So make sure to come back to Zacks for a full break down of CVS’ actual metrics after fellow giant Walmart (NYSE:WMT) reported stronger-than-expected fourth quarter financial results Tuesday.

Is Your Investment Advisor Fumbling Your Financial Future?

See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”

Click to get it free >>



Amazon.com, Inc. (AMZN): Free Stock Analysis Report

Walmart Inc. (WMT): Free Stock Analysis Report

Rite Aid Corporation (RAD): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.